Personalis (NASDAQ:PSNL) Posts Earnings Results, Misses Expectations By $0.58 EPS
Personalis (NASDAQ:PSNL) posted its quarterly earnings results on Tuesday. The company reported ($0.89) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.58), Briefing.com reports. The firm had revenue of $15.80 million for the quarter, compared to analyst estimates of $14.92 million. The firm’s revenue for the quarter was up 79.5% compared to the same quarter last year. Personalis updated its FY 2019 guidance to EPS.
NASDAQ:PSNL opened at $18.79 on Wednesday. The stock has a 50 day moving average price of $21.50. Personalis has a 52 week low of $14.25 and a 52 week high of $31.88.
In other news, Director Ken Ludlum acquired 70,000 shares of the company’s stock in a transaction that occurred on Monday, June 24th. The shares were purchased at an average price of $17.00 per share, for a total transaction of $1,190,000.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Personalis, Inc operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics.
Further Reading: What is an Initial Public Offering (IPO)?
Receive News & Ratings for Personalis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Personalis and related companies with MarketBeat.com's FREE daily email newsletter.